A Winning Guide to Pandemic Treaty Negotiations for MUN

Do not index

The pandemic treaty negotiations are, at their core, an attempt to build a global fire department before the next inferno starts. It’s a direct response to the hard lessons learned during the COVID-19 crisis, aiming to forge a legally binding pact so the world never again faces a pandemic so unprepared and divided.

The Story Behind the Pandemic Treaty

Think back to early 2020. The picture was grim. As COVID-19 exploded across the globe, it laid bare just how fragile our collective defenses were. Supply chains for basic essentials like masks and ventilators simply crumbled. Even the wealthiest nations found themselves scrambling.

Then came the scramble for vaccines. We saw a wave of "vaccine nationalism," where high-income countries bought up enough doses to inoculate their populations multiple times over, while developing nations were pushed to the back of the line.

The takeaway was brutal and obvious: our existing rulebook couldn't handle a crisis of this scale. The International Health Regulations (IHR) offered a framework for countries to report outbreaks, but they were toothless. They couldn’t compel the kind of global cooperation needed to manage supply chains or ensure fair access to lifesaving tools.

A Mandate Born from Crisis

Out of that chaos came a rare moment of political consensus. World leaders, seeing the devastation firsthand, agreed that something had to change. We couldn't just stumble into the next pandemic and repeat the same catastrophic mistakes. This recognition lit the fire for the formal pandemic treaty negotiations.

The starting gun fired in December 2021. Member states of the World Health Organization (WHO) created a new group, the Intergovernmental Negotiating Body (INB), with a single mission: draft and negotiate this new global agreement. The pressure was immense. The INB held an exhausting series of 13 formal negotiation rounds, with nine of them running deep into overtime as diplomats fought to find common ground. You can get a sense of the diplomatic grind on the UN News website.

This history is the "why" behind every article and every sticking point in the talks. It’s what turns your simulation from a theoretical debate into a reenactment of one of the most critical diplomatic moments of our time. As you prepare to tackle these issues, it’s worth diving deeper into what it takes for improving global pandemic preparedness on a systemic level.

Mapping the Negotiation Timeline and Key Players

To really get a grip on the pandemic treaty negotiations, you have to see it for what it was: a high-stakes diplomatic marathon. This wasn't a quick sprint; it was a multi-year slog driven by the collective trauma of COVID-19 and the urgent need to prevent a repeat.

It all formally began in December 2021. The World Health Assembly (WHA), which is the WHO's main decision-making forum, agreed to create a new body. This group, called the Intergovernmental Negotiating Body (INB), was handed one massive job: hammer out a brand-new international agreement on pandemic prevention, preparedness, and response.

The Diplomatic Marathon

The timeline for these negotiations was a long and winding road, stretching from December 2021 all the way to a final adoption on May 20, 2025. This journey was full of extensions, late-night debates, and moments where it seemed like the whole thing might fall apart.

As you can see from the timeline below, the path was anything but smooth. The original deadline of May 2024 came and went as countries dug in their heels on crucial issues, forcing everyone back to the table for another year.

Key Milestones in the Pandemic Agreement Negotiation

This table outlines the critical dates and events that shaped the pandemic treaty negotiation process, from its inception to the post-adoption phase.

Date	Event	Significance for Negotiations
Dec 2021	WHA establishes the Intergovernmental Negotiating Body (INB).	This was the official starting gun, creating the dedicated forum for member states to draft and negotiate the new agreement.
Late 2021	Global COVID-19 figures surpass 700 million cases, 7 million deaths.	The staggering human cost created immense political pressure and a shared sense of urgency to build a stronger global framework.
Feb 2023	The "zero draft" of the agreement is published.	This first complete draft served as the foundational text for negotiations, revealing the initial areas of both consensus and deep division.
May 2024	Original deadline for the final text passes without an agreement.	Deep disagreements, particularly on equity and financing, proved too difficult to resolve in time, forcing an extension.
May 20, 2025	The Pandemic Agreement is officially adopted by the WHA.	After intense final rounds of negotiation, a compromise text was achieved and formally adopted by member states.
May 2026	Target completion for the PABS system by the IGWG.	Key technical details were punted to a separate working group, showing that the work to operationalize the treaty is ongoing.

You can explore the full diplomatic journey and its key moments to understand the pandemic agreement's evolution.

Even with the agreement adopted, the work isn't done. Some of the trickiest parts, especially the mechanics of the Pathogen Access and Benefit-Sharing (PABS) system, were handed off to a separate working group. They have until the WHA meeting in May 2026 to iron out the details.

The Ecosystem of Influence

Now, while the INB was officially a negotiation between countries, it’s a rookie mistake to think only government delegates had a say. The reality is that a whole ecosystem of influential actors was constantly shaping the debate from the outside.

The WHO Secretariat: Think of the Secretariat as the essential backbone of the whole operation. They provided the technical know-how, drafted the initial texts that got the ball rolling, and often played the role of a neutral facilitator trying to find common ground.

Non-Governmental Organizations (NGOs) and Civil Society: These groups were the conscience of the negotiations. Organizations fighting for health equity and access to medicines were relentless, constantly pushing for stronger, fairer rules to protect developing nations and ensure transparency.

The Pharmaceutical Industry: On the other side of the table, you had powerful industry lobbies representing the major drug manufacturers. Their primary goal was protecting intellectual property and ensuring that any new rules wouldn't kill the financial incentive for innovation. Their voice was especially loud in any discussion about patents or the PABS system.

Philanthropic Foundations: Don't underestimate the "soft power" of major foundations. By funding global health research and initiatives, they help set the agenda and shape the terms of the debate, giving them a powerful, albeit indirect, seat at the table.

Understanding this web of influence is crucial for any delegate. Your country’s position is never formed in a vacuum; it’s constantly being pulled and pushed by these powerful forces. For a closer look at how these kinds of bodies work within the UN system, check out our guide on the roles of different United Nations committees.

Breaking Down the Core Negotiation Issues

The pandemic treaty negotiations weren't some dry, diplomatic affair. They were a pressure cooker where the world’s deepest divisions over health, wealth, and justice came to a boil. To really get what the final agreement means, you have to understand the handful of core issues that had diplomats arguing for years. These weren't abstract legal points—they were arguments over life and death.

The road to this treaty was long and winding, as the timeline below shows. It wasn't a straight shot to the finish line.

That extended timeline tells a story in itself. It shows just how tough it was to get nearly 200 countries to agree on the incredibly sensitive topics we’re about to unpack.

The Great Equity Divide

If you boil it all down, the single biggest fight was over equity. The memory of COVID-19 "vaccine nationalism" was still raw. Everyone remembered how wealthy nations bought up nearly all the early vaccine supplies, forcing developing countries to the back of the line for months, even years.

This created a deep rift from day one. Developing countries, often speaking through blocs like the G77 and China, came to the table demanding a legally binding system to make sure that never happened again. They wanted firm guarantees for fair, affordable, and timely access to vaccines, tests, and treatments for all.

On the other side, many high-income countries agreed in principle but got nervous about iron-clad legal mandates. They worried about being forced to act against their own national interests or upending the pharmaceutical market. This fundamental clash between solidarity and sovereignty was the ghost in the room for the entire negotiation.

PABS: The Firewall Against "Pandemic Colonialism"

One of the most radical and contested ideas on the table was the Pathogen Access and Benefit-Sharing (PABS) system. Think of it as a global contract designed to stop what many call "pandemic colonialism."

Here's the old, broken model: researchers from rich countries take a virus sample from a developing nation, use it to create a blockbuster vaccine or drug, and then sell it back to the world at prices the original country could never afford. PABS was designed to shatter that cycle.

The urgency for this system came directly from the COVID-19 experience. By mid-2022, after vaccines were developed with viral data from all over the world, poorer countries had received less than 20% of all doses. The PABS system is meant to be the fix.

As you can imagine, this was a major point of contention. You can read a report from the WHO to see how countries are moving forward with these complex talks.

The Battle Over Intellectual Property

Tied directly to the PABS debate was the fiery issue of intellectual property (IP). Developing nations pushed hard for the ability to temporarily waive drug patents during a pandemic. This would allow them to authorize widespread generic production of life-saving medicines and vaccines, making them affordable and available much faster.

This wasn't a new idea; it builds on existing flexibilities in global trade law for public health emergencies.

But pharmaceutical companies and the governments of their home countries pushed back, and they pushed back hard. Their argument is that strong IP protection is what drives innovation. Without the promise of a profitable patent, they say, companies won’t sink billions into the risky business of R&D. The final text landed on a weak compromise, merely "encouraging" voluntary tech transfer, which keeps the power firmly in the hands of patent holders.

Surveillance Versus Sovereignty

Another major friction point was finding the right balance between global disease surveillance and national sovereignty. To stop the next pandemic before it starts, the world needs countries to share data about new pathogens quickly and transparently. Early warnings are everything.

At the same time, many nations were deeply skeptical of giving an international body like the WHO too much authority. The treaty text walks a very fine line here. It confirms that states are ultimately in charge of their own public health but encourages cooperation. It stops short of giving the WHO the power to order countries around, respecting the political reality of national sovereignty. You can learn more about how different nations handle this balance by exploring various infectious diseases response strategies.

Finally, the question of who pays for all this hung over every single discussion. It takes a staggering amount of money to strengthen health systems, build manufacturing plants in the Global South, and run a global pandemic fund. Developing countries wanted a dedicated fund with mandatory contributions from rich nations. Wealthier countries, however, preferred using existing financial structures and making voluntary donations. The result is a system that tries to do both but ultimately depends on the political goodwill of donors, leaving its long-term funding on shaky ground.

Understanding the Geopolitics and Negotiation Blocs

The pandemic treaty negotiations weren't just a dry, technical exercise in public health law. Far from it. They were a raw, unfiltered reflection of global power dynamics, directly pitting the interests of the world’s wealthiest nations against the urgent demands of the Global South. To build alliances and draft effective resolutions as an MUN delegate, you first have to understand these geopolitical fault lines.

Think of the negotiating room as a microcosm of the world's economic and political divides. On one side, you had a massive coalition of developing countries. On the other, a group of high-income nations with a very different set of priorities. This fundamental split was the engine driving the entire debate.

The Voice of the Global South

The most powerful bloc was undoubtedly the Group of 77 and China (G77+China), a diverse coalition representing over 130 developing nations. Their message was unified, forged in the painful memory of the COVID-19 pandemic and the "vaccine nationalism" that left them behind.

Their non-negotiable demand was equity. They viewed this treaty as a once-in-a-generation chance to finally dismantle the systems that always put them at the back of the line for lifesaving medicines. The goal was to make equitable access a legally binding obligation, not just a feel-good suggestion.

Key priorities for the G77+China included:

A robust PABS system: They fought hard for the Pathogen Access and Benefit-Sharing (PABS) system. They saw it as the only real way to guarantee that sharing pathogen data would result in actual access to the vaccines and treatments developed from it.

Mandatory technology transfer: The bloc insisted on clauses that would compel pharmaceutical companies to share the know-how and technology needed for vaccine manufacturing in developing countries.

A dedicated pandemic fund: They argued for a brand-new, independent fund with mandatory contributions from wealthy nations to finance preparedness where it's needed most.

The Position of High-Income Nations

In the opposite corner were the high-income countries, often speaking through groups like the European Union (EU) or as individual developed nations. While they publicly supported goals like solidarity and preparedness, their primary focus was on protecting national economic interests and nurturing innovation through free-market principles.

These nations consistently argued that imposing strict, binding rules could suffocate the very private-sector innovation required to create new medicines in the first place. Their positions were often a clear reflection of the immense influence wielded by their domestic pharmaceutical industries.

The following table provides a snapshot of the primary negotiation blocs and their core stances on the most contentious issues.

Negotiation Blocs and Core Positions

Negotiation Bloc	Key Member Examples	Primary Position on Equity & PABS	Primary Position on Intellectual Property
G77+China	Brazil, India, South Africa, Indonesia	Advocates for a legally binding PABS system to guarantee access to resulting medical countermeasures as a condition for sharing pathogen data.	Pushes for mandatory technology transfer and temporary waivers of IP rights (like TRIPS waivers) during pandemics.
European Union	Germany, France, Italy	Prefers voluntary or non-binding PABS models that do not create barriers to rapid pathogen data sharing. Emphasizes capacity building.	Strongly opposes mandatory IP waivers, arguing that protecting patents is essential to incentivize private-sector R&D and innovation.
United States	United States	Supports rapid, open access to pathogen data but expresses concerns that a binding PABS system could hinder scientific research and response.	Firmly protects existing intellectual property frameworks, viewing them as critical for pharmaceutical innovation and investment.
African Group	Nigeria, Ethiopia, Kenya	A very strong and unified voice for a binding PABS system, viewing it as a matter of continental survival and justice.	Aligned with the G77+China, advocating for IP waivers and local manufacturing capabilities across Africa.

Understanding these different starting points is the key to seeing why compromise was so difficult to achieve. Each bloc was defending what it saw as its fundamental national or regional interest.

The Bridge-Builders and Swing States

Of course, not every country fit neatly into one of these two camps. A number of nations and regional groups took on the critical role of ‘bridge-builders,’ working behind the scenes to find common ground. Countries like South Africa and Brazil, while firmly aligned with the G77, often used their diplomatic skill to reframe radical demands into more negotiable proposals.

Similarly, regional bodies like the African Union (AU) were instrumental in consolidating their members' positions, giving them a much more unified and powerful voice at the table. These actors were absolutely essential in preventing a complete collapse of the talks, especially when debates over PABS and intellectual property became heated. For any global summit to function, effective multilingual communication is non-negotiable, allowing delegates to debate complex details in real-time across language barriers.

The intricate dance between these different blocs offers a fascinating real-world lesson in modern geopolitics and the art of building alliances.

Building Your Winning MUN Strategy

Alright, you've done your homework. You understand the core issues and you know which countries are friends and which are foes. But in Model UN, knowledge is just the starting point. Winning comes from turning that knowledge into influence—building alliances, shaping the conversation, and, most importantly, writing resolutions that actually solve the problem.

This is your playbook for the pandemic treaty negotiations.

The first, and most crucial, step is to get inside the head of your assigned country. This isn't just about skimming official statements. You need to feel the why behind their position.

If you’re representing a developing nation from the G77 bloc, for example, your arguments about the Pathogen Access and Benefit-Sharing (PABS) system can't be academic. They have to be steeped in the raw, frustrating memory of being at the back of the line for COVID-19 vaccines. Your speeches need that fire, that demand for justice born from real experience.

Mastering Your Country's Stance

To truly inhabit your role, dig into these three areas:

Economic Impact: How would a global pandemic fund or mandatory tech sharing hit your country's bottom line? Is it a cost or an investment?

Health Infrastructure: Can your country make its own vaccines? If the answer is no, then technology transfer isn't a talking point—it's a lifeline.

Political Ideology: Is your government a champion of global cooperation or a fierce defender of its own borders and sovereignty? This core belief will color every single thing you say and do.

Think of it like an actor prepping for a big role. You have to understand your character's deepest fears, their proudest ambitions, and their non-negotiable interests. You need to connect with it on an emotional level.

Drafting Operative Clauses with Impact

The real work of any MUN committee happens in the operative clauses. These are the action items, the nuts and bolts of your proposed solution. A weak clause is just wishful thinking, but a strong one is a blueprint for action. In the pandemic treaty negotiations, this difference is everything.

Let's look at two ways to write a clause on vaccine distribution.

Weak Clause:

Urges member states to ensure equitable vaccine distribution.

This sounds nice, but it’s completely toothless. What does "equitable" even mean here? There’s no accountability, no mechanism, no substance.

Strong Clause:

Decides that any manufacturer utilizing the Pathogen Access and Benefit-Sharing (PABS) system shall commit 20% of its real-time production of pandemic-related products, with 10% provided as a donation to the WHO and 10% made available at not-for-profit prices to developing countries.

Now that is a clause with teeth. It uses a commanding verb (Decides), lays out specific numbers (20%, 10%), names the responsible parties (manufacturers), and provides a clear mechanism (the PABS system). This is the kind of detail that drives debate and builds resolutions that matter.

Of course, a brilliant clause is useless if you can't get anyone to vote for it. That's where coalition-building comes in. No country can pass a resolution on its own. Use the informal "unmoderated caucuses" to hunt for allies. Start with delegates whose countries fall into the same negotiating blocs we covered earlier.

Your job is to frame your ideas as a win-win. For instance, when talking to a delegate from a developed nation, don't just talk about equity. Frame local manufacturing in the Global South as a strategic move to build stronger, more resilient global supply chains that prevent disruptions for everyone. True diplomacy is about understanding what the other side wants and showing them how your plan helps them get it. For delegates looking to sharpen these skills, our guide on essential negotiation techniques in diplomacy offers some great pointers.

Frequently Asked Questions About the Pandemic Treaty

As you get ready for your conference, a few key questions about the pandemic treaty will almost certainly come up. Let's tackle the big ones so you're fully prepared to navigate the debate.

Is the Pandemic Agreement Legally Binding?

Absolutely. The Pandemic Agreement adopted in May 2025 isn't just a set of recommendations; it’s a legally binding international treaty for every country that formally signs and ratifies it.

This authority comes directly from Article 19 of the WHO Constitution. It was designed this way on purpose to give the agreement real teeth, ensuring nations have mandatory obligations. This is a huge step up from previous health regulations, which often lacked the enforcement power needed during the COVID-19 crisis.

How Does the Pandemic Agreement Affect the IHR?

Think of the Pandemic Agreement and the International Health Regulations (IHR) as two parts of the same whole. They are designed to be complementary, not conflicting.

The IHR is the foundational rulebook for what happens inside a country. It sets the baseline for how a nation should be able to spot, report on, and respond to a public health threat on its own soil.

The Pandemic Agreement builds on this by creating a framework for how countries must work with each other. It specifically targets the huge gaps COVID-19 exposed, like ensuring fair access to vaccines, coordinating global supply chains, and funding pandemic preparedness.

What Is the One Health Approach in the Treaty?

The "One Health" approach is a core idea in the treaty that recognizes a simple but powerful truth: the health of humans, animals, and our shared environment are all deeply linked. This is critical because the vast majority of new infectious diseases, including those with pandemic potential, start in animals and jump to people (zoonotic spillover).

By keeping a close eye on diseases in wildlife and better managing the places where humans and animals interact, the goal is to stop the next pandemic before it even starts.

What Is the Status of the PABS System in 2026?

The Pathogen Access and Benefit-Sharing (PABS) system is still one of the hottest and most difficult topics of negotiation heading into 2026. While the main treaty framework was adopted in 2025, the nitty-gritty details of PABS were so contentious they had to be handed off to a separate working group.

Everyone agrees on the basic principle: countries that quickly share pathogen data should get real, tangible benefits in return, like affordable access to the vaccines and treatments developed from that data. The fight is over the "how." Fierce debates are still raging over the specific contribution levels for manufacturers and how the entire system will be governed, making it a prime subject for MUN simulations.

Ready to master every aspect of your MUN preparation? Model Diplomat is your AI-powered co-delegate, providing expert research, speech writing assistance, and strategic guidance for any committee. Walk into your next conference with the confidence of a seasoned diplomat by visiting https://modeldiplomat.com.